A NF-κB inhibitor, SUN C8079 has ever been used in vivo to prevent the development of myocarditis caused by the encephalomyocarditis virus (EMCV) and inhibit the expression of pro-inflammatory cytokines in cardiac tissues [44]. The gene discussed is NFKB1; the disease is myocarditis.